OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal Corticosteroid Treatment on Recovery of Long‐Term Olfactory Dysfunction Due to COVID‐19
Masoumeh Hosseinpoor, Mona Kabiri, Mohsen Rajati, et al.
The Laryngoscope (2022) Vol. 132, Iss. 11, pp. 2209-2216
Open Access | Times Cited: 23

Showing 23 citing articles:

Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID
Jun-Won Seo, Seong Eun Kim, Yoonjung Kim, et al.
Infection and Chemotherapy (2024) Vol. 56, Iss. 1, pp. 122-122
Open Access | Times Cited: 20

Nasal sprays for treating COVID-19: a scientific note
Vivek P. Chavda, Kajal Baviskar, Dixa A. Vaghela, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 2, pp. 249-265
Open Access | Times Cited: 26

Pharmacologic and Nonpharmacologic Treatment of Long COVID: A Meta-narrative Review
Bala Munipalli, Nancy L. Dawson, J. Calvo Rosales, et al.
SN Comprehensive Clinical Medicine (2025) Vol. 7, Iss. 1
Closed Access

Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction
Constantin A. Hintschich, Melanie Dietz, Antje Haehner, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1483-1483
Open Access | Times Cited: 18

Tackling persistent neurological symptoms in patients following acute COVID-19 infection: an update of the literature
Eder Cáceres, Afshin A. Divani, André Emilio Viñán Garcés, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-17
Open Access | Times Cited: 3

Neurochemical Alterations Linked to Persistent COVID-19-Induced Anosmia: Probing Into Orbitofrontal Cortex by Magnetic Resonance Spectroscopy
Mohammad Haghani Dogahe, Abbas Monsef, Elahe Abbaspour, et al.
Academic Radiology (2025)
Closed Access

Exploring the research landscape of COVID-19-induced olfactory dysfunction: A bibliometric study
Zhirong Yang, Yukun Ma, Wei Bi, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6

Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Ashna Mahadev, Firas Hentati, Brevin Miller, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 12, pp. 1111-1111
Open Access | Times Cited: 5

Therapeutic Efficacy of Nasal Corticosteroids in COVID‐19‐Related Olfactory Dysfunction: A Comprehensive Systematic Review and Meta‐analysis
Rudong Chen, Cong-wen Yang, Xiaobin Chen, et al.
Otolaryngology (2023) Vol. 170, Iss. 4, pp. 999-1008
Closed Access | Times Cited: 4

Early corticosteroid treatment enhances recovery from SARS-CoV-2 induced loss of smell in hamster
Laetitia Merle-Nguyen, Ophélie Ando-Grard, Clara Bourgon, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 78-89
Open Access | Times Cited: 1

Treatment of COVID-19 Associated Olfactory Dysfunction: A Systematic Review
S.C. Bischoff, Maximiliaan Moyaert, Marnick Clijsters, et al.
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Magnetic resonance spectroscopy findings of brain olfactory areas in patients with COVID‐19‐related anosmia: A preliminary comparative study
Shadman Nemati, Mohammad Haghani Dogahe, Alia Saberi, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery (2023) Vol. 10, Iss. 2, pp. 105-112
Open Access | Times Cited: 3

Corticosteroids for COVID-19-induced olfactory dysfunction: A comprehensive systematic review and meta-analysis of randomized controlled trials
Jian‐Ying Wang, Jiunn-Bey Pao, Chih‐Hsin Lee, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0289172-e0289172
Open Access | Times Cited: 3

Inhaled corticosteroids’ effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
Yasra Badi, Mohamed Hammad, Abdelrahman Tawfik, et al.
Canadian Journal of Respiratory Therapy (2023) Vol. 59
Open Access | Times Cited: 2

Sensory disorders, neuroinflammation, and COVID-19
Pietro De Luca, Arianna Di Stadio
Elsevier eBooks (2024), pp. 273-284
Closed Access

Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19
Mohamed H. Abdelazim, Faisal Alsenani, Mohammed Alnuhait, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 11, pp. 5793-5799
Closed Access

Maximizing Participation in Olfactory Training in a Sample with Post-COVID-19 Olfactory Loss
Alice Helena Delgado‐Lima, Jaime Bouhaben, María Luisa Delgado‐Losada
Brain Sciences (2024) Vol. 14, Iss. 7, pp. 730-730
Open Access

In reference to Intranasal Corticosteroid Treatment on Recovery of Long‐Term Olfactory Dysfunction Due to COVID‐19
Luigi Angelo Vaira, Giacomo De Riu, Paolo Boscolo–Rizzo, et al.
The Laryngoscope (2022) Vol. 133, Iss. 4
Open Access | Times Cited: 2

In response to Intranasal Corticosteroid Treatment on Recovery of Long‐Term Olfactory Dysfunction Due to COVID‐19
Masoumeh Hosseinpoor, Mona Kabiri, Mehdi Bakhshaee
The Laryngoscope (2022) Vol. 133, Iss. 4
Open Access | Times Cited: 1

Efficacy of topical steroids for the treatment of olfactory disorders caused by COVID‐19: A systematic review and meta‐analysis
Maryam Emadzadeh, Mona Kabiri
Clinical Otolaryngology (2023) Vol. 48, Iss. 4, pp. 721-722
Closed Access

The Effect of Corticosteroids on Post-Covid-19 Smell Loss: A Meta-Analysis.
Mona Kabiri, Maryam Emadzadeh
PubMed (2023) Vol. 35, Iss. 130, pp. 235-246
Closed Access

Page 1

Scroll to top